Senate Committee on Health, Education, Labor, and Pensions

S. 2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, with an amendment in the nature of a substitute; S. 4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, with an amendment in the nature of a substitute; S. 4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, with an amendment in the nature of a substitute; S. 5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, with an amendment in the nature of a substitute; S. 1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, with an amendment in the nature of a substitute; S. 3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, with an amendment in the nature of a substitute; S. 3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, with an amendment in the nature of a substitute; S. 494, to establish a national plan to coordinate research on epilepsy, with an amendment in the nature of a substitute; S. 4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, with an amendment in the nature of a substitute; S. 1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, with an amendment in the nature of a substitute; and S. 380, to improve obstetric emergency care, with an amendment in the nature of a substitute.

S. 4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, with an amendment in the nature of a substitute; S. 4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, with an amendment in the nature of a substitute; S. 4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, with an amendment in the nature of a substitute; S. 5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, with an amendment in the nature of a substitute; S. 1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, with an amendment in the nature of a substitute; S. 3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, with an amendment in the nature of a substitute; S. 3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, with an amendment in the nature of a substitute; S. 494, to establish a national plan to coordinate research on epilepsy, with an amendment in the nature of a substitute; S. 4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, with an amendment in the nature of a substitute; S. 1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, with an amendment in the nature of a substitute; and S. 380, to improve obstetric emergency care, with an amendment in the nature of a substitute.

S. 4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, with an amendment in the nature of a substitute; S. 4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, with an amendment in the nature of a substitute; S. 4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, with an amendment in the nature of a substitute; S. 5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, with an amendment in the nature of a substitute; S. 1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, with an amendment in the nature of a substitute; S. 3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, with an amendment in the nature of a substitute; S. 3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, with an amendment in the nature of a substitute; S. 494, to establish a national plan to coordinate research on epilepsy, with an amendment in the nature of a substitute; S. 4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, with an amendment in the nature of a substitute; S. 1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, with an amendment in the nature of a substitute; and S. 380, to improve obstetric emergency care, with an amendment in the nature of a substitute.

S. 5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, with an amendment in the nature of a substitute; S. 4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, with an amendment in the nature of a substitute; S. 4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, with an amendment in the nature of a substitute; S. 5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, with an amendment in the nature of a substitute; S. 1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, with an amendment in the nature of a substitute; S. 3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, with an amendment in the nature of a substitute; S. 3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, with an amendment in the nature of a substitute; S. 494, to establish a national plan to coordinate research on epilepsy, with an amendment in the nature of a substitute; S. 4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, with an amendment in the nature of a substitute; S. 1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, with an amendment in the nature of a substitute; and S. 380, to improve obstetric emergency care, with an amendment in the nature of a substitute.

S. 1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, with an amendment in the nature of a substitute; S. 4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, with an amendment in the nature of a substitute; S. 4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, with an amendment in the nature of a substitute; S. 5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, with an amendment in the nature of a substitute; S. 1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, with an amendment in the nature of a substitute; S. 3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, with an amendment in the nature of a substitute; S. 3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, with an amendment in the nature of a substitute; S. 494, to establish a national plan to coordinate research on epilepsy, with an amendment in the nature of a substitute; S. 4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, with an amendment in the nature of a substitute; S. 1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, with an amendment in the nature of a substitute; and S. 380, to improve obstetric emergency care, with an amendment in the nature of a substitute.

S. 3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, with an amendment in the nature of a substitute; S. 4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, with an amendment in the nature of a substitute; S. 4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, with an amendment in the nature of a substitute; S. 5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, with an amendment in the nature of a substitute; S. 1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, with an amendment in the nature of a substitute; S. 3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, with an amendment in the nature of a substitute; S. 3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, with an amendment in the nature of a substitute; S. 494, to establish a national plan to coordinate research on epilepsy, with an amendment in the nature of a substitute; S. 4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, with an amendment in the nature of a substitute; S. 1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, with an amendment in the nature of a substitute; and S. 380, to improve obstetric emergency care, with an amendment in the nature of a substitute.

S. 3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, with an amendment in the nature of a substitute; S. 4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, with an amendment in the nature of a substitute; S. 4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, with an amendment in the nature of a substitute; S. 5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, with an amendment in the nature of a substitute; S. 1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, with an amendment in the nature of a substitute; S. 3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, with an amendment in the nature of a substitute; S. 3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, with an amendment in the nature of a substitute; S. 494, to establish a national plan to coordinate research on epilepsy, with an amendment in the nature of a substitute; S. 4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, with an amendment in the nature of a substitute; S. 1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, with an amendment in the nature of a substitute; and S. 380, to improve obstetric emergency care, with an amendment in the nature of a substitute.

S. 494, to establish a national plan to coordinate research on epilepsy, with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, with an amendment in the nature of a substitute; S. 4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, with an amendment in the nature of a substitute; S. 4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, with an amendment in the nature of a substitute; S. 5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, with an amendment in the nature of a substitute; S. 1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, with an amendment in the nature of a substitute; S. 3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, with an amendment in the nature of a substitute; S. 3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, with an amendment in the nature of a substitute; S. 494, to establish a national plan to coordinate research on epilepsy, with an amendment in the nature of a substitute; S. 4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, with an amendment in the nature of a substitute; S. 1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, with an amendment in the nature of a substitute; and S. 380, to improve obstetric emergency care, with an amendment in the nature of a substitute.

S. 4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, with an amendment in the nature of a substitute; S. 4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, with an amendment in the nature of a substitute; S. 4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, with an amendment in the nature of a substitute; S. 5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, with an amendment in the nature of a substitute; S. 1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, with an amendment in the nature of a substitute; S. 3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, with an amendment in the nature of a substitute; S. 3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, with an amendment in the nature of a substitute; S. 494, to establish a national plan to coordinate research on epilepsy, with an amendment in the nature of a substitute; S. 4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, with an amendment in the nature of a substitute; S. 1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, with an amendment in the nature of a substitute; and S. 380, to improve obstetric emergency care, with an amendment in the nature of a substitute.

S. 1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, with an amendment in the nature of a substitute; S. 4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, with an amendment in the nature of a substitute; S. 4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, with an amendment in the nature of a substitute; S. 5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, with an amendment in the nature of a substitute; S. 1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, with an amendment in the nature of a substitute; S. 3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, with an amendment in the nature of a substitute; S. 3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, with an amendment in the nature of a substitute; S. 494, to establish a national plan to coordinate research on epilepsy, with an amendment in the nature of a substitute; S. 4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, with an amendment in the nature of a substitute; S. 1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, with an amendment in the nature of a substitute; and S. 380, to improve obstetric emergency care, with an amendment in the nature of a substitute.

S. 380, to improve obstetric emergency care, with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, with an amendment in the nature of a substitute; S. 4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, with an amendment in the nature of a substitute; S. 4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, with an amendment in the nature of a substitute; S. 5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, with an amendment in the nature of a substitute; S. 1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, with an amendment in the nature of a substitute; S. 3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, with an amendment in the nature of a substitute; S. 3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, with an amendment in the nature of a substitute; S. 494, to establish a national plan to coordinate research on epilepsy, with an amendment in the nature of a substitute; S. 4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, with an amendment in the nature of a substitute; S. 1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, with an amendment in the nature of a substitute; and S. 380, to improve obstetric emergency care, with an amendment in the nature of a substitute.

Committee ordered favorably reported the nominations of Brett Matsumoto, of Maryland, to be Commissioner of Labor Statistics, Department of Labor, James Macy, of Wisconsin, and David M. Prouty, of Maryland, both to be a Member of the National Labor Relations Board, and Michael McDonald, of the District of Columbia, to be Chairperson of the National Endowment for the Humanities

Committee ordered favorably reported the nominations of Brett Matsumoto, of Maryland, to be Commissioner of Labor Statistics, Department of Labor, James Macy, of Wisconsin, and David M. Prouty, of Maryland, both to be a Member of the National Labor Relations Board, and Michael McDonald, of the District of Columbia, to be Chairperson of the National Endowment for the Humanities.

S. 1782, to prohibit discrimination on the basis of mental or physical disability in cases of organ transplants, with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 1782, to prohibit discrimination on the basis of mental or physical disability in cases of organ transplants, with an amendment in the nature of a substitute; S. 3799, to amend the Public Health Service Act to reauthorize the Healthy Start Initiative, with an amendment; S. 4109, to reauthorize the Stem Cell Therapeutic and Research Act of 2005, with an amendment in the nature of a substitute; S. 2339, to reauthorize the Young Women's Breast Health Education and Awareness Requires Learning Young Act of 2009, with an amendment in the nature of a substitute; S. 4472, to amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, with an amendment in the nature of a substitute; S. 2658, to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office, with an amendment in the nature of a substitute; and S. 1954, to improve the requirements for making a determination of interchangeability of a biological product and its reference product, with an amendment in the nature of a substitute.

S. 3799, to amend the Public Health Service Act to reauthorize the Healthy Start Initiative, with an amendment

Committee ordered favorably reported the following business items: S. 1782, to prohibit discrimination on the basis of mental or physical disability in cases of organ transplants, with an amendment in the nature of a substitute; S. 3799, to amend the Public Health Service Act to reauthorize the Healthy Start Initiative, with an amendment; S. 4109, to reauthorize the Stem Cell Therapeutic and Research Act of 2005, with an amendment in the nature of a substitute; S. 2339, to reauthorize the Young Women's Breast Health Education and Awareness Requires Learning Young Act of 2009, with an amendment in the nature of a substitute; S. 4472, to amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, with an amendment in the nature of a substitute; S. 2658, to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office, with an amendment in the nature of a substitute; and S. 1954, to improve the requirements for making a determination of interchangeability of a biological product and its reference product, with an amendment in the nature of a substitute.

S. 4109, to reauthorize the Stem Cell Therapeutic and Research Act of 2005, with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 1782, to prohibit discrimination on the basis of mental or physical disability in cases of organ transplants, with an amendment in the nature of a substitute; S. 3799, to amend the Public Health Service Act to reauthorize the Healthy Start Initiative, with an amendment; S. 4109, to reauthorize the Stem Cell Therapeutic and Research Act of 2005, with an amendment in the nature of a substitute; S. 2339, to reauthorize the Young Women's Breast Health Education and Awareness Requires Learning Young Act of 2009, with an amendment in the nature of a substitute; S. 4472, to amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, with an amendment in the nature of a substitute; S. 2658, to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office, with an amendment in the nature of a substitute; and S. 1954, to improve the requirements for making a determination of interchangeability of a biological product and its reference product, with an amendment in the nature of a substitute.

S. 2339, to reauthorize the Young Women's Breast Health Education and Awareness Requires Learning Young Act of 2009, with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 1782, to prohibit discrimination on the basis of mental or physical disability in cases of organ transplants, with an amendment in the nature of a substitute; S. 3799, to amend the Public Health Service Act to reauthorize the Healthy Start Initiative, with an amendment; S. 4109, to reauthorize the Stem Cell Therapeutic and Research Act of 2005, with an amendment in the nature of a substitute; S. 2339, to reauthorize the Young Women's Breast Health Education and Awareness Requires Learning Young Act of 2009, with an amendment in the nature of a substitute; S. 4472, to amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, with an amendment in the nature of a substitute; S. 2658, to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office, with an amendment in the nature of a substitute; and S. 1954, to improve the requirements for making a determination of interchangeability of a biological product and its reference product, with an amendment in the nature of a substitute.

S. 4472, to amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 1782, to prohibit discrimination on the basis of mental or physical disability in cases of organ transplants, with an amendment in the nature of a substitute; S. 3799, to amend the Public Health Service Act to reauthorize the Healthy Start Initiative, with an amendment; S. 4109, to reauthorize the Stem Cell Therapeutic and Research Act of 2005, with an amendment in the nature of a substitute; S. 2339, to reauthorize the Young Women's Breast Health Education and Awareness Requires Learning Young Act of 2009, with an amendment in the nature of a substitute; S. 4472, to amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, with an amendment in the nature of a substitute; S. 2658, to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office, with an amendment in the nature of a substitute; and S. 1954, to improve the requirements for making a determination of interchangeability of a biological product and its reference product, with an amendment in the nature of a substitute.

S. 2658, to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office, with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 1782, to prohibit discrimination on the basis of mental or physical disability in cases of organ transplants, with an amendment in the nature of a substitute; S. 3799, to amend the Public Health Service Act to reauthorize the Healthy Start Initiative, with an amendment; S. 4109, to reauthorize the Stem Cell Therapeutic and Research Act of 2005, with an amendment in the nature of a substitute; S. 2339, to reauthorize the Young Women's Breast Health Education and Awareness Requires Learning Young Act of 2009, with an amendment in the nature of a substitute; S. 4472, to amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, with an amendment in the nature of a substitute; S. 2658, to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office, with an amendment in the nature of a substitute; and S. 1954, to improve the requirements for making a determination of interchangeability of a biological product and its reference product, with an amendment in the nature of a substitute.

S. 1954, to improve the requirements for making a determination of interchangeability of a biological product and its reference product, with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 1782, to prohibit discrimination on the basis of mental or physical disability in cases of organ transplants, with an amendment in the nature of a substitute; S. 3799, to amend the Public Health Service Act to reauthorize the Healthy Start Initiative, with an amendment; S. 4109, to reauthorize the Stem Cell Therapeutic and Research Act of 2005, with an amendment in the nature of a substitute; S. 2339, to reauthorize the Young Women's Breast Health Education and Awareness Requires Learning Young Act of 2009, with an amendment in the nature of a substitute; S. 4472, to amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, with an amendment in the nature of a substitute; S. 2658, to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office, with an amendment in the nature of a substitute; and S. 1954, to improve the requirements for making a determination of interchangeability of a biological product and its reference product, with an amendment in the nature of a substitute.

S. 1602, to coordinate Federal research and development efforts focused on modernizing mathematics in STEM education through mathematical and statistical modeling, including data-driven and computational thinking, problem, project, and performance-based learning and assessment, interdisciplinary exploration, and career connections

Committee ordered favorably reported the following business items: S. 1602, to coordinate Federal research and development efforts focused on modernizing mathematics in STEM education through mathematical and statistical modeling, including data-driven and computational thinking, problem, project, and performance-based learning and assessment, interdisciplinary exploration, and career connections; S. 3747, to amend the Higher Education Act of 1965 to recognize students who have completed secondary school education in a home school setting as high school graduates; S. 1552, to promote and protect from discrimination living organ donors, with an amendment in the nature of a substitute; and S. 3315, to require the Secretary of Health and Human Services and the Director of the Cybersecurity and Infrastructure Security Agency to coordinate to improve cybersecurity in the health care and public health sectors with an amendment in the nature of a substitute.

S. 3747, to amend the Higher Education Act of 1965 to recognize students who have completed secondary school education in a home school setting as high school graduates

Committee ordered favorably reported the following business items: S. 1602, to coordinate Federal research and development efforts focused on modernizing mathematics in STEM education through mathematical and statistical modeling, including data-driven and computational thinking, problem, project, and performance-based learning and assessment, interdisciplinary exploration, and career connections; S. 3747, to amend the Higher Education Act of 1965 to recognize students who have completed secondary school education in a home school setting as high school graduates; S. 1552, to promote and protect from discrimination living organ donors, with an amendment in the nature of a substitute; and S. 3315, to require the Secretary of Health and Human Services and the Director of the Cybersecurity and Infrastructure Security Agency to coordinate to improve cybersecurity in the health care and public health sectors with an amendment in the nature of a substitute.

S. 1552, to promote and protect from discrimination living organ donors, with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 1602, to coordinate Federal research and development efforts focused on modernizing mathematics in STEM education through mathematical and statistical modeling, including data-driven and computational thinking, problem, project, and performance-based learning and assessment, interdisciplinary exploration, and career connections; S. 3747, to amend the Higher Education Act of 1965 to recognize students who have completed secondary school education in a home school setting as high school graduates; S. 1552, to promote and protect from discrimination living organ donors, with an amendment in the nature of a substitute; and S. 3315, to require the Secretary of Health and Human Services and the Director of the Cybersecurity and Infrastructure Security Agency to coordinate to improve cybersecurity in the health care and public health sectors with an amendment in the nature of a substitute.

S. 3315, to require the Secretary of Health and Human Services and the Director of the Cybersecurity and Infrastructure Security Agency to coordinate to improve cybersecurity in the health care and public health sectors with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 1602, to coordinate Federal research and development efforts focused on modernizing mathematics in STEM education through mathematical and statistical modeling, including data-driven and computational thinking, problem, project, and performance-based learning and assessment, interdisciplinary exploration, and career connections; S. 3747, to amend the Higher Education Act of 1965 to recognize students who have completed secondary school education in a home school setting as high school graduates; S. 1552, to promote and protect from discrimination living organ donors, with an amendment in the nature of a substitute; and S. 3315, to require the Secretary of Health and Human Services and the Director of the Cybersecurity and Infrastructure Security Agency to coordinate to improve cybersecurity in the health care and public health sectors with an amendment in the nature of a substitute.

S. 1157, to direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 1157, to direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, with an amendment in the nature of a substitute; S. 921, to direct the Secretary of Health and Human Services to issue guidance on whether hospital emergency departments should implement fentanyl testing as a routine procedure for patients experiencing an overdose, with an amendment in the nature of a substitute; S. 2169, to require the development of a comprehensive rural hospital cybersecurity workforce development strategy, with an amendment in the nature of a substitute; and S. 272, to improve the safety of infant formula through testing of infant formula for microorganisms and toxic elements with an amendment in the nature of a substitute.

S. 921, to direct the Secretary of Health and Human Services to issue guidance on whether hospital emergency departments should implement fentanyl testing as a routine procedure for patients experiencing an overdose, with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 1157, to direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, with an amendment in the nature of a substitute; S. 921, to direct the Secretary of Health and Human Services to issue guidance on whether hospital emergency departments should implement fentanyl testing as a routine procedure for patients experiencing an overdose, with an amendment in the nature of a substitute; S. 2169, to require the development of a comprehensive rural hospital cybersecurity workforce development strategy, with an amendment in the nature of a substitute; and S. 272, to improve the safety of infant formula through testing of infant formula for microorganisms and toxic elements with an amendment in the nature of a substitute.

S. 2169, to require the development of a comprehensive rural hospital cybersecurity workforce development strategy, with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 1157, to direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, with an amendment in the nature of a substitute; S. 921, to direct the Secretary of Health and Human Services to issue guidance on whether hospital emergency departments should implement fentanyl testing as a routine procedure for patients experiencing an overdose, with an amendment in the nature of a substitute; S. 2169, to require the development of a comprehensive rural hospital cybersecurity workforce development strategy, with an amendment in the nature of a substitute; and S. 272, to improve the safety of infant formula through testing of infant formula for microorganisms and toxic elements with an amendment in the nature of a substitute.

S. 272, to improve the safety of infant formula through testing of infant formula for microorganisms and toxic elements with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 1157, to direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, with an amendment in the nature of a substitute; S. 921, to direct the Secretary of Health and Human Services to issue guidance on whether hospital emergency departments should implement fentanyl testing as a routine procedure for patients experiencing an overdose, with an amendment in the nature of a substitute; S. 2169, to require the development of a comprehensive rural hospital cybersecurity workforce development strategy, with an amendment in the nature of a substitute; and S. 272, to improve the safety of infant formula through testing of infant formula for microorganisms and toxic elements with an amendment in the nature of a substitute.

Committee ordered favorably reported the nominations of Scott Mayer, of Pennsylvania, to be a Member of the National Labor Relations Board for the term of five years, and Mary Anne Carter, of Tennessee, to be Chairperson of the National Endowment for the Arts for a term of four years

Committee ordered favorably reported the nominations of Scott Mayer, of Pennsylvania, to be a Member of the National Labor Relations Board for the term of five years, and Mary Anne Carter, of Tennessee, to be Chairperson of the National Endowment for the Arts for a term of four years.

Committee ordered favorably reported the nominations of Crystal Carey, of New Jersey, to be General Counsel, and James Murphy, of Maryland, to be a Member, both of the National Labor Relations Board, and Rosario Palmieri, of Virginia, to be an Assistant Secretary, and Anthony D'Esposito, of New York, to be Inspector General, both of the Department of Labor

Committee ordered favorably reported the nominations of Crystal Carey, of New Jersey, to be General Counsel, and James Murphy, of Maryland, to be a Member, both of the National Labor Relations Board, and Rosario Palmieri, of Virginia, to be an Assistant Secretary, and Anthony D'Esposito, of New York, to be Inspector General, both of the Department of Labor.

S. 2292, to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 2292, to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, with an amendment in the nature of a substitute; S. 1440, to amend title II of the Public Health Service Act to include as an additional right or privilege of commissioned officers of the Public Health Service (and their beneficiaries) certain leave provided under title 10, United States Code to commissioned officers of the Army (or their beneficiaries); S. 2398, to reauthorize the Kay Hagan Tick Act, with an amendment in the nature of a substitute; S. 2301, to reauthorize certain programs regarding rural health care; S. 1728, to amend the Employee Retirement Income Security Act of 1974 to expand the membership of the Advisory Council on Employee Welfare and Pension Benefit Plans to include representatives of employee ownership organizations, with an amendment in the nature of a substitute; and S. 2403, to amend the Employee Retirement Income Security Act of 1974 to provide a clear definition of adequate consideration for certain closely held stock, with an amendment in the nature of a substitute.

S. 1440, to amend title II of the Public Health Service Act to include as an additional right or privilege of commissioned officers of the Public Health Service (and their beneficiaries) certain leave provided under title 10, United States Code to commissioned officers of the Army (or their beneficiaries)

Committee ordered favorably reported the following business items: S. 2292, to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, with an amendment in the nature of a substitute; S. 1440, to amend title II of the Public Health Service Act to include as an additional right or privilege of commissioned officers of the Public Health Service (and their beneficiaries) certain leave provided under title 10, United States Code to commissioned officers of the Army (or their beneficiaries); S. 2398, to reauthorize the Kay Hagan Tick Act, with an amendment in the nature of a substitute; S. 2301, to reauthorize certain programs regarding rural health care; S. 1728, to amend the Employee Retirement Income Security Act of 1974 to expand the membership of the Advisory Council on Employee Welfare and Pension Benefit Plans to include representatives of employee ownership organizations, with an amendment in the nature of a substitute; and S. 2403, to amend the Employee Retirement Income Security Act of 1974 to provide a clear definition of adequate consideration for certain closely held stock, with an amendment in the nature of a substitute.

S. 2398, to reauthorize the Kay Hagan Tick Act, with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 2292, to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, with an amendment in the nature of a substitute; S. 1440, to amend title II of the Public Health Service Act to include as an additional right or privilege of commissioned officers of the Public Health Service (and their beneficiaries) certain leave provided under title 10, United States Code to commissioned officers of the Army (or their beneficiaries); S. 2398, to reauthorize the Kay Hagan Tick Act, with an amendment in the nature of a substitute; S. 2301, to reauthorize certain programs regarding rural health care; S. 1728, to amend the Employee Retirement Income Security Act of 1974 to expand the membership of the Advisory Council on Employee Welfare and Pension Benefit Plans to include representatives of employee ownership organizations, with an amendment in the nature of a substitute; and S. 2403, to amend the Employee Retirement Income Security Act of 1974 to provide a clear definition of adequate consideration for certain closely held stock, with an amendment in the nature of a substitute.

S. 2301, to reauthorize certain programs regarding rural health care

Committee ordered favorably reported the following business items: S. 2292, to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, with an amendment in the nature of a substitute; S. 1440, to amend title II of the Public Health Service Act to include as an additional right or privilege of commissioned officers of the Public Health Service (and their beneficiaries) certain leave provided under title 10, United States Code to commissioned officers of the Army (or their beneficiaries); S. 2398, to reauthorize the Kay Hagan Tick Act, with an amendment in the nature of a substitute; S. 2301, to reauthorize certain programs regarding rural health care; S. 1728, to amend the Employee Retirement Income Security Act of 1974 to expand the membership of the Advisory Council on Employee Welfare and Pension Benefit Plans to include representatives of employee ownership organizations, with an amendment in the nature of a substitute; and S. 2403, to amend the Employee Retirement Income Security Act of 1974 to provide a clear definition of adequate consideration for certain closely held stock, with an amendment in the nature of a substitute.

S. 1728, to amend the Employee Retirement Income Security Act of 1974 to expand the membership of the Advisory Council on Employee Welfare and Pension Benefit Plans to include representatives of employee ownership organizations, with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 2292, to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, with an amendment in the nature of a substitute; S. 1440, to amend title II of the Public Health Service Act to include as an additional right or privilege of commissioned officers of the Public Health Service (and their beneficiaries) certain leave provided under title 10, United States Code to commissioned officers of the Army (or their beneficiaries); S. 2398, to reauthorize the Kay Hagan Tick Act, with an amendment in the nature of a substitute; S. 2301, to reauthorize certain programs regarding rural health care; S. 1728, to amend the Employee Retirement Income Security Act of 1974 to expand the membership of the Advisory Council on Employee Welfare and Pension Benefit Plans to include representatives of employee ownership organizations, with an amendment in the nature of a substitute; and S. 2403, to amend the Employee Retirement Income Security Act of 1974 to provide a clear definition of adequate consideration for certain closely held stock, with an amendment in the nature of a substitute.

S. 2403, to amend the Employee Retirement Income Security Act of 1974 to provide a clear definition of adequate consideration for certain closely held stock, with an amendment in the nature of a substitute

Committee ordered favorably reported the following business items: S. 2292, to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, with an amendment in the nature of a substitute; S. 1440, to amend title II of the Public Health Service Act to include as an additional right or privilege of commissioned officers of the Public Health Service (and their beneficiaries) certain leave provided under title 10, United States Code to commissioned officers of the Army (or their beneficiaries); S. 2398, to reauthorize the Kay Hagan Tick Act, with an amendment in the nature of a substitute; S. 2301, to reauthorize certain programs regarding rural health care; S. 1728, to amend the Employee Retirement Income Security Act of 1974 to expand the membership of the Advisory Council on Employee Welfare and Pension Benefit Plans to include representatives of employee ownership organizations, with an amendment in the nature of a substitute; and S. 2403, to amend the Employee Retirement Income Security Act of 1974 to provide a clear definition of adequate consideration for certain closely held stock, with an amendment in the nature of a substitute.

Committee ordered favorably reported the nominations of David Brian Castillo, of Washington, to be Chief Financial Officer, Department of Labor, Brian Christine, of Alabama, to be an Assistant Secretary of Health and Human Services, Brittany Panuccio, of Florida, to be a Member of the Equal Employment Opportunity Commission for a term expiring July 1, 2029, Jonathan Snare, of Virginia, to be a Member of the Occupational Safety and Health Review Commission for a term expiring…

Committee ordered favorably reported the nominations of David Brian Castillo, of Washington, to be Chief Financial Officer, Department of Labor, Brian Christine, of Alabama, to be an Assistant Secretary of Health and Human Services, Brittany Panuccio, of Florida, to be a Member of the Equal Employment Opportunity Commission for a term expiring July 1, 2029, Jonathan Snare, of Virginia, to be a Member of the Occupational Safety and Health Review Commission for a term expiring April 27, 2029, David Barker, of Iowa, to be Assistant Secretary for Postsecondary Education, and Mary Riley, of the District of Columbia, to be Assistant Secretary for Legislation and Congressional Affairs, both of the Department of Education.

Committee ordered favorably reported the nomination of Susan Monarez, of Wisconsin, to be Director of the Centers for Disease Control and Prevention, Department of Health and Human Services

Committee ordered favorably reported the nomination of Susan Monarez, of Wisconsin, to be Director of the Centers for Disease Control and Prevention, Department of Health and Human Services.

Committee ordered favorably reported the nominations of Penny Schwinn, of Tennessee, to be Deputy Secretary, and Kimberly Richey, of Texas, to be Assistant Secretary for Civil Rights, both of the Department of Education, and Daniel Aronowitz, of Virginia, and David Keeling, of Kentucky, both to be an Assistant Secretary, Jonathan Berry, of Maryland, to be Solicitor, Andrew Rogers, of Virginia, to be Administrator of the Wage and Hour Division, Andrea Lucas, of Virginia, to b…

Committee ordered favorably reported the nominations of Penny Schwinn, of Tennessee, to be Deputy Secretary, and Kimberly Richey, of Texas, to be Assistant Secretary for Civil Rights, both of the Department of Education, and Daniel Aronowitz, of Virginia, and David Keeling, of Kentucky, both to be an Assistant Secretary, Jonathan Berry, of Maryland, to be Solicitor, Andrew Rogers, of Virginia, to be Administrator of the Wage and Hour Division, Andrea Lucas, of Virginia, to be a Member of the Equal Employment Opportunity Commission, and Jeremiah Workman, of Ohio, to be Assistant Secretary for Veterans' Employment and Training, all of the Department of Labor.

Committee ordered favorably reported the nominations of Julie Hocker, of Virginia, to be an Assistant Secretary, Wayne Palmer, of Virginia, to be Assistant Secretary for Mine Safety and Health, and Henry Mack III, of Florida, to be an Assistant Secretary, all of the Department of Labor, Marco Rajkovich, Jr., of Virginia, to be a Member of the Federal Mine Safety and Health Review Commission, and Kirsten Baesler, of North Dakota, to be Assistant Secretary for Elementary and S…

Committee ordered favorably reported the nominations of Julie Hocker, of Virginia, to be an Assistant Secretary, Wayne Palmer, of Virginia, to be Assistant Secretary for Mine Safety and Health, and Henry Mack III, of Florida, to be an Assistant Secretary, all of the Department of Labor, Marco Rajkovich, Jr., of Virginia, to be a Member of the Federal Mine Safety and Health Review Commission, and Kirsten Baesler, of North Dakota, to be Assistant Secretary for Elementary and Secondary Education, Kevin O'Farrell, of Florida, to be Assistant Secretary for Career, Technical, and Adult Education, and Nicholas Kent, of Virginia, to be Under Secretary, all of the Department of Education.

Committee ordered favorably reported the nomination of Janet Dhillon, of Virginia, to be Director of the Pension Benefit Guaranty Corporation

Committee ordered favorably reported the nomination of Janet Dhillon, of Virginia, to be Director of the Pension Benefit Guaranty Corporation.

S. 558

Committee began consideration of S. 558, to provide for the consideration of a definition of antisemitism set forth by the International Holocaust Remembrance Alliance for the enforcement of Federal antidiscrimination laws concerning education programs or activities, and S. 163, to require institutions of higher education participating in Federal student aid programs to share information about title VI of the Civil Rights Act of 1964, including a link to the webpage of the Office for Civil Rights where an individual can submit a complaint regarding discrimination in violation of such title, but did not complete action thereon and adjourned.

S. 163

Committee began consideration of S. 558, to provide for the consideration of a definition of antisemitism set forth by the International Holocaust Remembrance Alliance for the enforcement of Federal antidiscrimination laws concerning education programs or activities, and S. 163, to require institutions of higher education participating in Federal student aid programs to share information about title VI of the Civil Rights Act of 1964, including a link to the webpage of the Office for Civil Rights where an individual can submit a complaint regarding discrimination in violation of such title, but did not complete action thereon and adjourned.

Committee ordered favorably reported the nominations of Jayanta Bhattacharya, of California, to be Director of the National Institutes of Health, and Martin Makary, of Virginia, to be Commissioner of Food and Drugs, both of the Department of Health and Human Services

Committee ordered favorably reported the nominations of Jayanta Bhattacharya, of California, to be Director of the National Institutes of Health, and Martin Makary, of Virginia, to be Commissioner of Food and Drugs, both of the Department of Health and Human Services.

Committee ordered favorably reported the nomination of Keith Sonderling, of Florida, to be Deputy Secretary of Labor

Committee ordered favorably reported the nomination of Keith Sonderling, of Florida, to be Deputy Secretary of Labor.

Committee ordered favorably reported the nomination of Lori Chavez-DeRemer, of Oregon, to be Secretary of Labor

Committee ordered favorably reported the nomination of Lori Chavez-DeRemer, of Oregon, to be Secretary of Labor.

Committee ordered favorably reported the nomination of Linda McMahon, of Connecticut, to be Secretary of Education

Committee ordered favorably reported the nomination of Linda McMahon, of Connecticut, to be Secretary of Education.

S.Res. 76

Committee ordered favorably reported an original resolution (S. Res. 76) authorizing expenditures by the Committee for the 119th Congress

Committee ordered favorably reported the committee rules for the 119th Congress

Committee ordered favorably reported the committee rules for the 119th Congress.